HomeRGT • ASX
add
Argent BioPharma Ltd
Previous close
$0.13
Day range
$0.14 - $0.14
Year range
$0.12 - $0.57
Market cap
8.59M AUD
Avg Volume
34.96K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 2.14K | -99.29% |
Operating expense | 4.38M | 7.88% |
Net income | -6.08M | -71.86% |
Net profit margin | -283.89K | -23,952.02% |
Earnings per share | — | — |
EBITDA | -4.11M | -9.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 718.39K | -88.92% |
Total assets | 3.06M | -82.35% |
Total liabilities | 13.94M | -16.33% |
Total equity | -10.88M | — |
Shares outstanding | 50.67M | — |
Price to book | -0.60 | — |
Return on assets | -358.26% | — |
Return on capital | 716.52% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -6.08M | -71.86% |
Cash from operations | -2.14M | 45.93% |
Cash from investing | -1.13K | 86.59% |
Cash from financing | 2.15M | -69.64% |
Net change in cash | 7.76K | -99.75% |
Free cash flow | -2.74M | -29.79% |
About
CEO
Founded
2005
Website